Matches in SemOpenAlex for { <https://semopenalex.org/work/W96366985> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W96366985 endingPage "71" @default.
- W96366985 startingPage "363" @default.
- W96366985 abstract "Mixed cryoglobulinemia (MC) is an important complication of hepatitis C virus (HCV) infection. Antiviral therapy is now an important approach for symptomatic HCV-MC; some information exists on IFN mono-therapy for symptomatic HCV-MC in the non-transplant setting, but its efficacy is still unclear.We evaluated efficacy and safety of mono-therapy with standard or pegylated interferon (IFN) for symptomatic HCV-associated MC in non-immunosuppressed individuals by performing a systematic review of the literature with a meta-analysis of clinical studies. We used the random-effects model of DerSimonian and Laird with heterogeneity and sensitivity analyses. The primary outcome was sustained viral response (SVR, as a measure of efficacy), and the secondary outcome was the drop-out rate due to side-effects (as a measure of tolerability).We identified eleven clinical studies (n = 235 unique patients) ; the rate of baseline kidney involvement ranged between 11% and 74%. The summary estimate of frequency of sustained viral response was 0.15 with a 95% Confidence Interval (CI) of 0.08; 0.22 (random-effects model). Significant heterogeneity occurred (P= 0.001; Chi= 28.9%). Stratified analysis did not meaningfully change the results. The frequency of patients stopping antiviral agents was 3.4% ; most patients experienced minor side effects which did not require interruption of therapy. Baseline cirrhosis (P <0.04), kidney involvement (P <0.07), and arthralgias (P <0.04) showed negative impact on viral response. We found an excellent relationship between viral and clinical response [weighted K = 0.72 (95% CI, 0.54; 0.89)], by an evaluation at individual level on a subset of reports (n = 65 unique patients).This meta-analysis of clinical studies shows that antiviral therapy with standard or pegylated IFN alone for symptomatic MC associated with HCV gives satisfactory response in a minority of patients only. Clinical trials based on combination therapy (pegylated interferon plus ribavirin) or novel immunosuppressive agents are under way in order to improve efficacy and safety of symptomatic HCV-MC. ," @default.
- W96366985 created "2016-06-24" @default.
- W96366985 creator A5019989508 @default.
- W96366985 creator A5064594935 @default.
- W96366985 creator A5089723892 @default.
- W96366985 date "2013-12-01" @default.
- W96366985 modified "2023-09-23" @default.
- W96366985 title "Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies." @default.
- W96366985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24592538" @default.
- W96366985 hasPublicationYear "2013" @default.
- W96366985 type Work @default.
- W96366985 sameAs 96366985 @default.
- W96366985 citedByCount "3" @default.
- W96366985 countsByYear W963669852015 @default.
- W96366985 countsByYear W963669852019 @default.
- W96366985 countsByYear W963669852022 @default.
- W96366985 crossrefType "journal-article" @default.
- W96366985 hasAuthorship W96366985A5019989508 @default.
- W96366985 hasAuthorship W96366985A5064594935 @default.
- W96366985 hasAuthorship W96366985A5089723892 @default.
- W96366985 hasConcept C126322002 @default.
- W96366985 hasConcept C197934379 @default.
- W96366985 hasConcept C203014093 @default.
- W96366985 hasConcept C2522874641 @default.
- W96366985 hasConcept C2776408679 @default.
- W96366985 hasConcept C2776455275 @default.
- W96366985 hasConcept C2776461080 @default.
- W96366985 hasConcept C2777214474 @default.
- W96366985 hasConcept C2778375690 @default.
- W96366985 hasConcept C2780040827 @default.
- W96366985 hasConcept C44249647 @default.
- W96366985 hasConcept C71924100 @default.
- W96366985 hasConcept C90924648 @default.
- W96366985 hasConcept C95190672 @default.
- W96366985 hasConceptScore W96366985C126322002 @default.
- W96366985 hasConceptScore W96366985C197934379 @default.
- W96366985 hasConceptScore W96366985C203014093 @default.
- W96366985 hasConceptScore W96366985C2522874641 @default.
- W96366985 hasConceptScore W96366985C2776408679 @default.
- W96366985 hasConceptScore W96366985C2776455275 @default.
- W96366985 hasConceptScore W96366985C2776461080 @default.
- W96366985 hasConceptScore W96366985C2777214474 @default.
- W96366985 hasConceptScore W96366985C2778375690 @default.
- W96366985 hasConceptScore W96366985C2780040827 @default.
- W96366985 hasConceptScore W96366985C44249647 @default.
- W96366985 hasConceptScore W96366985C71924100 @default.
- W96366985 hasConceptScore W96366985C90924648 @default.
- W96366985 hasConceptScore W96366985C95190672 @default.
- W96366985 hasIssue "4" @default.
- W96366985 hasLocation W963669851 @default.
- W96366985 hasOpenAccess W96366985 @default.
- W96366985 hasPrimaryLocation W963669851 @default.
- W96366985 hasRelatedWork W2002362951 @default.
- W96366985 hasRelatedWork W2008626862 @default.
- W96366985 hasRelatedWork W2034228609 @default.
- W96366985 hasRelatedWork W2061501244 @default.
- W96366985 hasRelatedWork W2083785084 @default.
- W96366985 hasRelatedWork W2110258166 @default.
- W96366985 hasRelatedWork W2517087858 @default.
- W96366985 hasRelatedWork W2790035481 @default.
- W96366985 hasRelatedWork W651249740 @default.
- W96366985 hasRelatedWork W2467456162 @default.
- W96366985 hasVolume "76" @default.
- W96366985 isParatext "false" @default.
- W96366985 isRetracted "false" @default.
- W96366985 magId "96366985" @default.
- W96366985 workType "article" @default.